XML 23 R12.htm IDEA: XBRL DOCUMENT v3.25.1
Accounts payable and accrued expenses
3 Months Ended
Mar. 31, 2025
Payables and Accruals [Abstract]  
Accounts payable and accrued expenses

5.        Accounts payable and accrued expenses

Accounts payable and accrued expenses at March 31, 2025 and December 31, 2024 consist of the following:

March 31, 

December 31, 

    

2025

    

2024

Employee compensation, benefits, and related accruals

$

32,091

$

61,575

Income tax payable

64,622

4,701

Consulting and contracted research

 

16,497

 

19,909

Sales allowance

 

60,801

 

58,644

Sales rebates

 

102,443

 

101,613

Royalties

7,305

8,953

Accounts payable

 

15,150

 

17,274

Milestone payable

11,025

Other

 

18,898

 

20,598

Total

$

317,807

$

304,292

As of March 31, 2025, the Company does not have any accrued restructuring costs included above within employee compensation, benefits, and related accruals. As of December 31, 2024, there were $0.1 million of accrued restructuring costs included above within employee compensation, benefits, and related accruals from a reduction in workforce in the year ended December 31, 2023 in connection with the Company’s strategic pipeline prioritization and discontinuation of its preclinical and early research programs in its gene therapy platform.